3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell, Peripheral
3
Myelodysplastic Syndromes
2
Lymphoma, T-Cell
2
Leukemia, Myeloid, Acute
2
Uveal Melanoma
1
Neuroendocrine Tumors
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Leukemia-Lymphoma, Adult T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Eye Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Neuroendocrine
1
Blast Crisis
1
Interventions
Specimen Handling
3
Biopsy
3
Azacitidine
2
venetoclax
1
veliparib
1
ruxolitinib
1
pevonedistat
1
peginterferon alfa-2b
1
onvansertib
1
fludarabine phosphate
1
axatilimab
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation Conditioning
1
Topotecan
1
Therapeutics
1
Tacrolimus
1
Sirolimus
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Hyperbaric Oxygenation
1
High-Energy Shock Waves
1
Geriatric Assessment
1
Ganciclovir
1
Foscarnet
1
Flow Cytometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
belinostat
×
1 year
×
Clear all
No trials found.